应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01548 金斯瑞生物科技
已收盘 07-23 16:08:27
13.160
-0.240
-1.79%
最高
13.580
最低
13.160
成交量
990.25万
今开
13.500
昨收
13.400
日振幅
3.13%
总市值
280.00亿
流通市值
280.00亿
总股本
21.28亿
成交额
1.32亿
换手率
0.47%
流通股本
21.28亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
港股异动 | CRO概念股集体上涨 头部公司新签订单金额双位数增长 板块有望迎来边际改善
智通财经 · 07-22 10:10
港股异动 | CRO概念股集体上涨 头部公司新签订单金额双位数增长 板块有望迎来边际改善
金斯瑞生物科技07月19日遭主力抛售1191万元 环比增加314.98%
自选股智能写手 · 07-19
金斯瑞生物科技07月19日遭主力抛售1191万元 环比增加314.98%
港股异动 | 金斯瑞生物科技(01548)转跌逾4% 传奇生物不对收购传闻发表评论 公司或面临壳化风险
智通财经 · 07-19
港股异动 | 金斯瑞生物科技(01548)转跌逾4% 传奇生物不对收购传闻发表评论 公司或面临壳化风险
金斯瑞生物科技(01548)下跌2.84%,报13.02元/股
金融界 · 07-19
金斯瑞生物科技(01548)下跌2.84%,报13.02元/股
港股异动 | 金斯瑞生物科技(01548)涨超3% CARVYKTI第二季度贸易销售净额约1.86亿美元
智通财经 · 07-19
港股异动 | 金斯瑞生物科技(01548)涨超3% CARVYKTI第二季度贸易销售净额约1.86亿美元
金斯瑞生物科技7月18日遭南向资金减持276.43万股
自选股智能写手 · 07-19
金斯瑞生物科技7月18日遭南向资金减持276.43万股
金斯瑞生物科技7月17日遭南向资金减持518.06万股
自选股智能写手 · 07-18
金斯瑞生物科技7月17日遭南向资金减持518.06万股
港股公告掘金 | 时代电气预期上半年归母净利约15.07亿元 同比增长30.56%
智通财经 · 07-17
港股公告掘金 | 时代电气预期上半年归母净利约15.07亿元 同比增长30.56%
金斯瑞生物科技(01548):CARVYKTI®第二季度贸易销售净额约1.86亿美元
智通财经 · 07-17
金斯瑞生物科技(01548):CARVYKTI®第二季度贸易销售净额约1.86亿美元
CRO概念股早盘持续走高 泰格医药涨超6%金斯瑞生物科技涨超5%
新浪港股 · 07-17
CRO概念股早盘持续走高 泰格医药涨超6%金斯瑞生物科技涨超5%
港股异动 | CRO概念股集体上涨 美联储降息将近叠加利好政策频出 板块有望迎边际改善
智通财经 · 07-17
港股异动 | CRO概念股集体上涨 美联储降息将近叠加利好政策频出 板块有望迎边际改善
医保基金对创新药支付的提升空间巨大,港股创新药ETF(159567)实时成交额突破4028万元,金斯瑞生物科技、昭衍新药、泰格医药领涨。
和讯网 · 07-17
医保基金对创新药支付的提升空间巨大,港股创新药ETF(159567)实时成交额突破4028万元,金斯瑞生物科技、昭衍新药、泰格医药领涨。
金斯瑞生物科技(01548)上涨5.79%,报13.16元/股
金融界 · 07-17
金斯瑞生物科技(01548)上涨5.79%,报13.16元/股
金斯瑞生物科技盘中异动 快速拉升5.79%
自选股智能写手 · 07-17
金斯瑞生物科技盘中异动 快速拉升5.79%
港股异动 | 金斯瑞生物科技(01548)回落逾4% 总市值超250亿港元 报道称传奇生物或收到并购要约
智通财经 · 07-16
港股异动 | 金斯瑞生物科技(01548)回落逾4% 总市值超250亿港元 报道称传奇生物或收到并购要约
新基金“子弹”密集供应!这个赛道突然爆发
券商中国 · 07-15
新基金“子弹”密集供应!这个赛道突然爆发
金斯瑞生物科技(01548.HK):不知悉股价或成交量波动原因
阿斯达克财经 · 07-15
金斯瑞生物科技(01548.HK):不知悉股价或成交量波动原因
金斯瑞生物科技(01548):股份价格及成交量不寻常波动 不知悉原因
智通财经 · 07-15
金斯瑞生物科技(01548):股份价格及成交量不寻常波动 不知悉原因
港股异动 | 金斯瑞午后一度涨近30%,旗下传奇生物或被溢价收购
老虎资讯综合 · 07-15
港股异动 | 金斯瑞午后一度涨近30%,旗下传奇生物或被溢价收购
传奇生物收到并购要约?母公司金斯瑞股价大涨26.20%
第一财经 · 07-15
传奇生物收到并购要约?母公司金斯瑞股价大涨26.20%
公司概况
公司名称:
金斯瑞生物科技
所属市场:
SEHK
上市日期:
--
主营业务:
制造及销售生命科学研究产品及服务。产品及服务主要包括生命科学研究服务、临床前药物研发服务、生命科学研究目录产品及工业合成生物产品。
发行价格:
--
{"stockData":{"symbol":"01548","market":"HK","secType":"STK","nameCN":"金斯瑞生物科技","latestPrice":13.16,"timestamp":1721722107028,"preClose":13.4,"halted":0,"volume":9902500,"delay":0,"floatShares":2127686517,"shares":2127686517,"eps":-0.35339633,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.24,"latestTime":"07-23 16:08:27","open":13.5,"high":13.58,"low":13.16,"amount":132160582,"amplitude":0.031343,"askPrice":13.18,"askSize":28000,"bidPrice":13.16,"bidSize":70000,"shortable":3,"etf":0,"ttmEps":-0.35367738913179264,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721784600000},"adr":0,"listingDate":1451404800000,"adjPreClose":13.4,"openAndCloseTimeList":[[1721698200000,1721707200000],[1721710800000,1721721600000]],"volumeRatio":0.459185,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01548/wiki","defaultTab":"wiki","newsList":[{"id":"2453785081","title":"港股异动 | CRO概念股集体上涨 头部公司新签订单金额双位数增长 板块有望迎来边际改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2453785081","media":"智通财经","labels":["Business Data"],"top":-1,"share":"https://www.laohu8.com/m/news/2453785081?lang=zh_cn&edition=full","pubTime":"2024-07-22 10:10","pubTimestamp":1721614253,"startTime":"0","endTime":"0","summary":"从上半年整体来看,预计公司营业收入同比阶段性略有下降;公司全球客户询单和访问同比有所回暖,新签订单金额同比增长超过15%。此前,凯莱英公布上半年新签订单同比增长超过20%。该行认为,CXO板块在经历业绩、估值双杀之后,有望迎来边际改善。方正证券认为,国内CXO企业正快步向新兴领域延伸,拓展新品类,并加快相关布局,希望承接全球相关产能需求,在未来五年的成长之路收获新增量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153726.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0140636845.USD","LU0043850808.USD","LU1242518857.USD","LU0359201612.USD","HK0000320223.HKD","LU0819121731.USD","LU0039217434.USD","LU1720050803.USD","LU0307460666.USD","LU0417516902.SGD","BK1141","LU0417516738.SGD","LU0181495838.USD","LU0516422366.SGD","SG9999002562.SGD","LU0516423174.USD","03759","HSTECH","HSCEI","03347","YANG","LU0572944931.SGD","SG9999002463.SGD","LU0456846285.SGD","LU0516422440.USD","LU0326950275.SGD","LU0052750758.USD","BK1576","LU0051755006.USD","LU0516423091.SGD","LU0708995583.HKD","BK1521","02269","LU0588546209.SGD","LU2039709279.SGD","LU0823426480.USD","IE00B0JY6N72.USD","LU0320764599.SGD","LU0348735423.USD","LU0348825331.USD","BK1589","LU0516422952.EUR","LU0979878070.USD","LU0327786744.USD","LU1794554557.SGD","LU1242518931.SGD","LU1688375341.USD","01548","BK1583"],"gpt_icon":1},{"id":"2452845441","title":"金斯瑞生物科技07月19日遭主力抛售1191万元 环比增加314.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452845441","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452845441?lang=zh_cn&edition=full","pubTime":"2024-07-19 16:15","pubTimestamp":1721376909,"startTime":"0","endTime":"0","summary":"07月19日, 金斯瑞生物科技股价跌2.39%,报收13.08元,成交金额3.79亿元,换手率1.33%,振幅9.10%,量比0.87。金斯瑞生物科技今日主力资金净流出1191万元,上一交易日主力净流出287万元,今日环比增加314.98%。该股近5个交易日上涨29.20%,主力资金累计净流入4196万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入5847万元,其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071916152495db836b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071916152495db836b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000320223.HKD","HK0000306701.USD","BK1576","HK0000320264.USD","HK0000306685.HKD","BK1141","01548","BK1583"],"gpt_icon":0},{"id":"2452410039","title":"港股异动 | 金斯瑞生物科技(01548)转跌逾4% 传奇生物不对收购传闻发表评论 公司或面临壳化风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2452410039","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452410039?lang=zh_cn&edition=full","pubTime":"2024-07-19 15:15","pubTimestamp":1721373303,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,金斯瑞生物科技早盘延续近期涨势,盘中一度涨超4%,午后股价转跌,尾盘跌幅扩大逾4%。传奇生物方面表示,企业方不会对此市场传闻发表任何评论。据悉,金斯瑞生物持有传奇生物47.96%的股份。如果最终将传奇生物授出,收获的现金远超金斯瑞当前市值,但公司未来存在“壳”化风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153084.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK1576","BK4505","HK0000320223.HKD","BK1141","BK4585","HK0000306701.USD","HSCEI","HK0000306685.HKD","HK0000320264.USD","HSTECH","YANG","01548","LEGN","BK1583","BK4139"],"gpt_icon":1},{"id":"2452412965","title":"金斯瑞生物科技(01548)下跌2.84%,报13.02元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452412965","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452412965?lang=zh_cn&edition=full","pubTime":"2024-07-19 14:36","pubTimestamp":1721371012,"startTime":"0","endTime":"0","summary":"7月19日,金斯瑞生物科技(01548)盘中下跌2.84%,截至14:36,报13.02元/股,成交3.0亿元。金斯瑞生物科技股份有限公司是一家全球重要的生命科学研发与生产服务提供商,主要业务包括生命科学服务及产品、生物医药合同研发生产、工业合成产品和综合性全球细胞疗法。截至2022年12月31日,公司在全球拥有6213名员工,拥有超过210项授权专利与800多项专利申请,业务覆盖全球100多个国家和地区,为20余万客户提供服务与产品。截至2023年年报,金斯瑞生物科技营业总收入59.46亿元、净利润-6.76亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/19143641669041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","HK0000320223.HKD","HK0000306701.USD","BK1576","01548","HK0000320264.USD","HK0000306685.HKD","BK1583"],"gpt_icon":0},{"id":"2452401493","title":"港股异动 | 金斯瑞生物科技(01548)涨超3% CARVYKTI第二季度贸易销售净额约1.86亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452401493","media":"智通财经","labels":["Business Data"],"top":-1,"share":"https://www.laohu8.com/m/news/2452401493?lang=zh_cn&edition=full","pubTime":"2024-07-19 09:51","pubTimestamp":1721353872,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,金斯瑞生物科技涨超3%,截至发稿,涨3.28%,报13.84港元,成交额8117.35万港元。消息面上,金斯瑞生物科技发布公告,传奇生物科技股份有限公司已于2024年7月17日向美国证监会提交6-K表格,并宣布,根据传奇生物与Janssen Biotech,Inc.(杨森)于2017年12月21日订立的合作及许可协议,CARVYKTI于截至2024年6月30日止季度产生贸易销售净额约1.86亿美元。交银国际此前发布研究报告称,维持金斯瑞生物科技“买入”评级,目标价27.75港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1152985.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000320264.USD","HK0000306685.HKD","BK1583","BK1576","01548","HK0000320223.HKD","YANG","BK1141","HSTECH","HK0000306701.USD","HSCEI"],"gpt_icon":1},{"id":"2452495130","title":"金斯瑞生物科技7月18日遭南向资金减持276.43万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452495130","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452495130?lang=zh_cn&edition=full","pubTime":"2024-07-19 09:31","pubTimestamp":1721352694,"startTime":"0","endTime":"0","summary":"7月18日,南向资金减持金斯瑞生物科技276.43万股。截止当日收盘,港股通共持有金斯瑞生物科技51973.14万股,占流通股24.41%。金斯瑞生物科技近5个交易日上涨39.87%,港股通累计减持519.30万股;近20个交易日上涨52.27%,港股通累计减持1471.59万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407190942269f68729e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407190942269f68729e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000306685.HKD","01548","HK0000320264.USD","BK1576","HK0000320223.HKD","HK0000306701.USD","BK1141","BK1583"],"gpt_icon":0},{"id":"2452453861","title":"金斯瑞生物科技7月17日遭南向资金减持518.06万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452453861","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452453861?lang=zh_cn&edition=full","pubTime":"2024-07-18 09:31","pubTimestamp":1721266288,"startTime":"0","endTime":"0","summary":"7月17日,南向资金减持金斯瑞生物科技518.06万股。截止当日收盘,港股通共持有金斯瑞生物科技52249.58万股,占流通股24.54%。港股通减持金额前五个股分别为中国宏桥、中国海洋石油、安踏体育、中国石油股份、联想集团。金斯瑞生物科技近5个交易日上涨45.92%,港股通累计减持231.66万股;近20个交易日上涨50.57%,港股通累计减持1228.55万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071809431795d24c5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071809431795d24c5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","HK0000306685.HKD","BK1583","01548","BK1141","HK0000320223.HKD","HK0000306701.USD","HK0000320264.USD"],"gpt_icon":0},{"id":"2452516510","title":"港股公告掘金 | 时代电气预期上半年归母净利约15.07亿元 同比增长30.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452516510","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452516510?lang=zh_cn&edition=full","pubTime":"2024-07-17 22:59","pubTimestamp":1721228378,"startTime":"0","endTime":"0","summary":"【重大事项】宏华集团(00196)附属与中东客户签署合计金额超15亿元的智能钻机销售协议华润医药(03320)附属拟18.2亿元收购Green Cross HK的100%权益 并与GC Corp订立战略合作框架协议君实生物(01877):特瑞普利单抗联合贝伐珠单抗一线治疗晚期肝细胞癌的新适应症上市申请获得受理【财报数据】金斯瑞生物科技(01548):CARVYKTI第二季度贸易销售净额约1.86亿","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1152348.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688187","BK1576","BK1570","BK1583","BK1161","BK1191","HK0000306685.HKD","HSTECH","BK1141","HK0000306701.USD","01548","HK0000320264.USD","BK0279","03320","BK1565","IE0032431581.USD","HSCEI","HK0000320223.HKD","03898","YANG","01877","BK1515","BK1116","BK1171"],"gpt_icon":1},{"id":"2452615682","title":"金斯瑞生物科技(01548):CARVYKTI®第二季度贸易销售净额约1.86亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452615682","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452615682?lang=zh_cn&edition=full","pubTime":"2024-07-17 20:26","pubTimestamp":1721219173,"startTime":"0","endTime":"0","summary":"智通财经APP讯,金斯瑞生物科技(01548)发布公告,传奇生物科技股份有限公司(传奇生物,为公司非全资附属公司,其股份以美国存托股份形式于美国(美国)纳斯达克全球精选市场上市)已于2024年7月17日(纽约时间,于2024年7月17日香港交易时段后)向美国证监会提交6-K表格,并宣布,根据传奇生物与Janssen Biotech,Inc.(杨森)于2017年12月21日订立的合作及许可协议,CARVYKTI®于截至2024年6月30日止季度产生贸易销售净额约1.86亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1152288.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000320223.HKD","BK1141","HK0000306701.USD","HK0000320264.USD","01548","HK0000306685.HKD","BK1576","BK1583"],"gpt_icon":0},{"id":"2452905367","title":"CRO概念股早盘持续走高 泰格医药涨超6%金斯瑞生物科技涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452905367","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452905367?lang=zh_cn&edition=full","pubTime":"2024-07-17 11:47","pubTimestamp":1721188065,"startTime":"0","endTime":"0","summary":"CRO概念股早盘集体上涨 ,泰格医药(03347)上涨6.22%,报29.05港元;金斯瑞生物科技(01548)上涨5.47%,报13.12港元;凯莱英(06821)上涨4.31%,报47.20港元;康龙化成(03759)上涨4.20%,报8.94港元。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-17/doc-incemcmf3167808.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-17/doc-incemcmf3167808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["HK0000320264.USD","HK0000306685.HKD","BK1583","03347","BK1576","01548","HK0000320223.HKD","BK1141","HK0000306701.USD"],"gpt_icon":0},{"id":"2452908632","title":"港股异动 | CRO概念股集体上涨 美联储降息将近叠加利好政策频出 板块有望迎边际改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2452908632","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452908632?lang=zh_cn&edition=full","pubTime":"2024-07-17 10:56","pubTimestamp":1721185003,"startTime":"0","endTime":"0","summary":"消息面上,美国6月通胀超预期回落叠加鲍威尔频频“放鸽”,当前市场预测美联储九月降息概率升至100%。开源证券此前指出,随着美联储将进入降息周期,流动性改善有助于优化投融资环境并提高新药研发景气度,有望给估值仍处于底部的创新药标的带来更大的估值修复空间。另外,利好政策频出支持创新药产业发展。该行认为,CXO板块在经历业绩、估值双杀之后,有望迎来边际改善。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1151895.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ESmain","BK4550","HK0000306685.HKD","HK0000306701.USD","BK1583","OEF","BK4534",".SPX","OEX","BK4585","BK1141","01548","03347","BK4588","BK4581","SPY","SSO","IVV","SDS","BK1191","HK0000320264.USD","03759","YANG","UPRO","06821","BK4559","SH","BK1576","BK4504","HK0000320223.HKD","HSTECH","SPXU","HSCEI","07226"],"gpt_icon":0},{"id":"2452908580","title":"医保基金对创新药支付的提升空间巨大,港股创新药ETF(159567)实时成交额突破4028万元,金斯瑞生物科技、昭衍新药、泰格医药领涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2452908580","media":"和讯网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452908580?lang=zh_cn&edition=full","pubTime":"2024-07-17 10:26","pubTimestamp":1721183206,"startTime":"0","endTime":"0","summary":"盘面上,金斯瑞生物科技领涨,昭衍新药、泰格医药跟涨,港股创新药ETF市场热度较高,过去5个交易日日均成交额8703万元。2022年医保支付创新药金额为481.89亿元,仅占医保支出总额的1.96%,表明医保基金对创新药支付的提升空间巨大。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071711153095cc0655&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071711153095cc0655&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","HK0000306701.USD","06978","BK1576","603127","06127","BK1574","01548","03347","HK0000320264.USD","BK1583","BK1161","HK0000320223.HKD","HK0000306685.HKD"],"gpt_icon":0},{"id":"2452979658","title":"金斯瑞生物科技(01548)上涨5.79%,报13.16元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452979658","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452979658?lang=zh_cn&edition=full","pubTime":"2024-07-17 09:36","pubTimestamp":1721180209,"startTime":"0","endTime":"0","summary":"7月17日,金斯瑞生物科技(01548)盘中上涨5.79%,截至09:36,报13.16元/股,成交4819.05万元。金斯瑞生物科技股份有限公司是一家全球重要的生命科学研发与生产服务提供商,主要业务包括生命科学服务及产品、生物医药合同研发生产、工业合成产品和综合性全球细胞疗法。截至2022年12月31日,公司在全球拥有6213名员工,拥有超过210项授权专利与800多项专利申请,业务覆盖全球100多个国家和地区,为20余万客户提供服务与产品。截至2023年年报,金斯瑞生物科技营业总收入59.46亿元、净利润-6.76亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/17093641611842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["HK0000306701.USD","HK0000306685.HKD","BK1583","01548","HK0000320223.HKD","HK0000320264.USD","BK1141","BK1576"],"gpt_icon":0},{"id":"2452997615","title":"金斯瑞生物科技盘中异动 快速拉升5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452997615","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452997615?lang=zh_cn&edition=full","pubTime":"2024-07-17 09:36","pubTimestamp":1721180203,"startTime":"0","endTime":"0","summary":"2024年07月17日早盘09时36分,金斯瑞生物科技股票出现异动,股价急速上涨5.79%。金斯瑞生物科技股票所在的生物技术行业中,整体涨幅为0.23%。其相关个股中,金斯瑞生物科技、云顶新耀-B、科济药业-B涨幅较大,振幅较大的相关个股有盛禾生物-B、科济药业-B、云顶新耀-B,振幅分别为16.10%、4.76%、3.96%。金斯瑞生物科技公司简介:金斯瑞生物科技股份有限公司是一家主要从事生物科学研究及相关业务的香港投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717093643941f7940&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717093643941f7940&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","HK0000320223.HKD","BK1141","HK0000306701.USD","HK0000306685.HKD","HK0000320264.USD","01548","BK1583"],"gpt_icon":0},{"id":"2451982355","title":"港股异动 | 金斯瑞生物科技(01548)回落逾4% 总市值超250亿港元 报道称传奇生物或收到并购要约","url":"https://stock-news.laohu8.com/highlight/detail?id=2451982355","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451982355?lang=zh_cn&edition=full","pubTime":"2024-07-16 10:07","pubTimestamp":1721095650,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,金斯瑞生物科技回落逾4%,截至发稿,跌3.67%,报12.08港元,成交额1.68亿港元,总市值超250亿港元。消息面上,据报道,传奇生物近日收到并购邀约,并聘请投资银行Centerview Partners帮助其董事会审查收购要约和其他选择。据悉,传奇生物为金斯瑞生物的子公司,金斯瑞生物持股比例为47.96%。据业内猜测,若本次潜在收购以30%-50%溢价计算,收购价格或将在130-150亿美元之间,出售事项完成后,金斯瑞生物科技到手现金约451.9-521.4亿人民币。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1151331.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","BK4139","BK4505","HK0000306685.HKD","LEGN","BK1583","01548","BK4588","BK4585","BK1141","HSTECH","HK0000320223.HKD","HSCEI","YANG","07226","HK0000306701.USD","HK0000320264.USD"],"gpt_icon":0},{"id":"2451649684","title":"新基金“子弹”密集供应!这个赛道突然爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=2451649684","media":"券商中国","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451649684?lang=zh_cn&edition=full","pubTime":"2024-07-15 19:48","pubTimestamp":1721044108,"startTime":"0","endTime":"0","summary":"新基金“子弹”密集供应!这个赛道突然爆发","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hk.eastmoney.com/news/1533,202407153131387783.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"eastmoney_highlight","symbols":["BK1141","06978","BK1161","HK0000320223.HKD","HK0000306701.USD","HSCEI","01548","BK1515","BK1576","09939","HK0000320264.USD","07226","HK0000306685.HKD","HSTECH","BK1583","BK1574","YANG"],"gpt_icon":0},{"id":"2451695012","title":"金斯瑞生物科技(01548.HK):不知悉股价或成交量波动原因","url":"https://stock-news.laohu8.com/highlight/detail?id=2451695012","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451695012?lang=zh_cn&edition=full","pubTime":"2024-07-15 14:05","pubTimestamp":1721023500,"startTime":"0","endTime":"0","summary":"金斯瑞生物科技(01548.HK) 称,注意到公司股份价格及成交量近期有所上升。公司指,在作出合理查询后,没有知悉股价或成交量波动的任何原因。公司今早高开15%,最高见13.28元,升幅近33%。现报12.78元,升27.8%,成交量达6,560万股,成交金额录得8.12亿元。(vc/k)(港股报价延迟最少十五分钟。沽空资料截至 2024-07-15 12:25。)AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190702162421146_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190702162421146_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1363635/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1576","HK0000306685.HKD","HK0000320223.HKD","HK0000306701.USD","BK1141","01548","BK1583","HK0000320264.USD"],"gpt_icon":0},{"id":"2451695635","title":"金斯瑞生物科技(01548):股份价格及成交量不寻常波动 不知悉原因","url":"https://stock-news.laohu8.com/highlight/detail?id=2451695635","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451695635?lang=zh_cn&edition=full","pubTime":"2024-07-15 14:02","pubTimestamp":1721023358,"startTime":"0","endTime":"0","summary":"智通财经APP讯,金斯瑞生物科技(01548)发布公告,该公司董事会注意到公司股份价格及成交量近期有所上升。公司经作出在相关情况下有关公司的合理查询后,董事会确认截至本公告发布之时并没有知悉该等股价或成交量波动的任何原因,又或根据《证券及期货条例》(香港法例第571章)第XIVA部须予披露的任何内幕消息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1150799.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000320264.USD","BK1583","BK1141","HK0000320223.HKD","HK0000306701.USD","BK1576","HK0000306685.HKD","01548"],"gpt_icon":0},{"id":"1126208511","title":"港股异动 | 金斯瑞午后一度涨近30%,旗下传奇生物或被溢价收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1126208511","media":"老虎资讯综合","labels":["movement"],"top":-1,"share":"https://www.laohu8.com/m/news/1126208511?lang=zh_cn&edition=full","pubTime":"2024-07-15 13:15","pubTimestamp":1721020527,"startTime":"0","endTime":"0","summary":"7月15日, $金斯瑞生物科技$ 高开高走,午后一度涨近30%,截止发稿成交额已超7亿港元。传奇生物旗下的西达基奥仑赛是首个实现在海外上市的中国原创CAR-T细胞治疗药物,销售额持续增长,有望成为下一个\"十亿美元分子\"。自西达基奥仑赛海外上市以来,销售额持续在增长,2022年销售额为2.68亿美元,2023年已达到5亿美元。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN","01548"],"gpt_icon":0},{"id":"2451566040","title":"传奇生物收到并购要约?母公司金斯瑞股价大涨26.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451566040","media":"第一财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451566040?lang=zh_cn&edition=full","pubTime":"2024-07-15 13:00","pubTimestamp":1721019624,"startTime":"0","endTime":"0","summary":" 7月15日上午,在港股上市的金斯瑞生物科技股价大涨26.20%,股价大涨背后,与一则传言有关。 在过去的两天,市场传出消息称,金斯瑞生物科技旗下子公司传奇生物近日收到并购要约,并聘请投资银行Centerview Partners帮助其董事会审查收购要约和其他选择。市场更是猜测称,这或将促成截至目前中国最大Biotech并购案的诞生。 传奇生物7月12月美股股价大涨12.10%,市值录得99.11亿美元。 2024年第一季度,传奇生物净亏损为5980万美元,净亏损同比收窄46.65%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/roll/2024-07-15/doc-inceevpa2254602.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-07-15/doc-inceevpa2254602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["HK0000320264.USD","BK1583","BK1141","HK0000320223.HKD","HK0000306701.USD","BK1576","HK0000306685.HKD","01548"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0686},{"period":"1month","weight":0.5783},{"period":"3month","weight":0.2204},{"period":"6month","weight":-0.1759},{"period":"1year","weight":-0.2733},{"period":"ytd","weight":-0.3253}],"compareEarnings":[{"period":"1week","weight":-0.0211},{"period":"1month","weight":-0.0218},{"period":"3month","weight":0.048},{"period":"6month","weight":0.1092},{"period":"1year","weight":-0.0755},{"period":"ytd","weight":0.0345}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"制造及销售生命科学研究产品及服务。产品及服务主要包括生命科学研究服务、临床前药物研发服务、生命科学研究目录产品及工业合成生物产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":-0.012915},{"month":2,"riseRate":0.555556,"avgChangeRate":0.078892},{"month":3,"riseRate":0.555556,"avgChangeRate":-0.061679},{"month":4,"riseRate":0.555556,"avgChangeRate":0.055583},{"month":5,"riseRate":0.444444,"avgChangeRate":0.056395},{"month":6,"riseRate":0.555556,"avgChangeRate":0.032355},{"month":7,"riseRate":0.555556,"avgChangeRate":0.079194},{"month":8,"riseRate":0.375,"avgChangeRate":0.132663},{"month":9,"riseRate":0.375,"avgChangeRate":-0.108852},{"month":10,"riseRate":0.75,"avgChangeRate":0.142825},{"month":11,"riseRate":0.75,"avgChangeRate":0.077381},{"month":12,"riseRate":0.375,"avgChangeRate":0.084334}],"exchange":"SEHK","name":"金斯瑞生物科技","nameEN":"GENSCRIPT BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金斯瑞生物科技(01548)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金斯瑞生物科技(01548)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金斯瑞生物科技,01548,金斯瑞生物科技股票,金斯瑞生物科技股票老虎,金斯瑞生物科技股票老虎国际,金斯瑞生物科技行情,金斯瑞生物科技股票行情,金斯瑞生物科技股价,金斯瑞生物科技股市,金斯瑞生物科技股票价格,金斯瑞生物科技股票交易,金斯瑞生物科技股票购买,金斯瑞生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金斯瑞生物科技(01548)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金斯瑞生物科技(01548)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}